Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Pattern of human chorionic gonadotropin binding in the polycystic ovary

Journal Article · · American Journal of Obstetrics and Gynecology; (USA)
; ;  [1]
  1. McGill Univ., Montreal, Quebec (Canada)

The histologic evolution of polycystic ovaries in the estradiol valerate-treated rat coincides with the development of a unique plasma pattern of luteinizing hormone. To assess the role of luteinizing hormone in polycystic ovaries, it is necessary to evaluate the luteinizing hormone sensitivity of the specific tissues in the polycystic ovary. Therefore, we examined the pattern of luteinizing hormone binding sites in polycystic ovaries. Rats at 4 or 8 weeks after estradiol valerate treatment each received an intrajugular injection of iodine 125-labeled human chorionic gonadotropin. Some rats also received a 1000-fold excess of unlabeled human chorionic gonadotropin in the same injection. Ovaries were prepared for autoradiography. Dense accumulations of grains occurred over the theca of normal and atretic secondary follicles in all ovaries and over clusters of secondary interstitial cells. The iodine label was variable over the typically hypertrophied theca of precystic follicles. The theca of definitive cysts showed little or no label. These results indicate that cyst formation coincides with the loss of luteinizing hormone/human chorionic gonadotropin binding to the affected follicles.

OSTI ID:
5669610
Journal Information:
American Journal of Obstetrics and Gynecology; (USA), Journal Name: American Journal of Obstetrics and Gynecology; (USA) Vol. 161:2; ISSN AJOGA; ISSN 0002-9378
Country of Publication:
United States
Language:
English